who should not use semaglutide Semaglutide, also known as Ozempic, for weight loss - what you need to know Semaglutide Injection - Joy Medical

To prevent confounding, a new user design excluding patients with use of GLP1 or GIP/GLP1 RAs during the baseline period was used

It may also lower your risk of obesity-related conditions like heart attack and stroke

The total milligrams in the vial determine how many weeks of doses you can draw before needing a new vial, and this calculation changes depending on where you are in your dose escalation schedule

Hsia, T

Research indicates that gastrointestinal symptoms, including bloating, are substantially reduced after approximately 20 weeks of consistent use

However, since tirzepatide is a newer medication, there is still ongoing research to determine its long-term safety and side effects